Revenue of LEO Pharma 2009-2022
The revenues of the Danish pharmaceutical company LEO Pharma A/S fluctuated during the period from 2009 to 2022, but generally increased. The revenue amounted to around six billion Danish kroner in 2009, and in 2019 it amounted to a record high of 10.8 billion Danish kroner. The latest annual revenue, in 2022, stood at 10.6 billion Danish kroner. Leo Pharma is a Danish pharmaceutical company founded in 1908. The company's key product is dermatological pharmaceuticals, but they do also produce pharmaceuticals for other areas.
